| Net Cash Provided by (Used in) Operating Activities |
$-554,953 |
USD |
-81.09% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$897,000 |
USD |
46% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$-156,342 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
350,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
127,757,823 |
shares |
19% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$137,997 |
USD |
16% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$4,199,460 |
USD |
108% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
$4,199,460 |
USD |
108% |
Q3 2025 |
Q3 2025 |
| Depreciation |
$3,161 |
USD |
|
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$87,350 |
USD |
32% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$4,199,460 |
USD |
108% |
Q3 2025 |
Q3 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$14,305,138 |
USD |
22% |
Q3 2025 |
Q3 2025 |
| Current Federal Tax Expense (Benefit) |
$271,880 |
USD |
27% |
Q1 2025 |
Q1 2025 |
| Amortization of Intangible Assets |
$28,212 |
USD |
-74.65% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$320,975 |
USD |
-81.85% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$461,612 |
USD |
417% |
Q1 2024 |
Q1 2024 |